Last reviewed · How we verify
NCT03385837
Activity Level and Barriers to Participate of Cardiac Rehabilitation in Advanced Heart Failure Patients
trial in Heart Failure，Congestive in 70 participants. Completed in 30 December 2018.
30 November 2018
Quick facts
| Lead sponsor | Hospital Israelita Albert Einstein |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 1 March 2015 |
| Primary completion | 30 November 2018 |
| Estimated completion | 30 December 2018 |
| Sites | 1 location across Brazil |
Conditions studied
- Heart Failure，Congestive — all drugs for Heart Failure，Congestive →
- Cardiac Rehabilitation — all drugs for Cardiac Rehabilitation →
- Physical Exercise — all drugs for Physical Exercise →
Sponsor
Hospital Israelita Albert Einstein
Who can join
18 and older, any sex, with Heart Failure，Congestive or Cardiac Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective longitudinal and observational clinical study will be conducted with hospitalized heart failure patients.The main purpose is to know the level of physical activity of these patients after their discharge in relation to the orientation received during their hospitalization and identify the barriers perceived by these patients to participate in a cardiac rehabilitation program. The outcomes are available by telephone calls in 30 and 90 days after discharge.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Barriers to cardiac rehabilitation and their association with hospital readmission in patients with heart failure.
Carvalho ACSM, Groehs RV, Pereira C, Soares VL, et al · · 2025 · PMID 40105570 · DOI 10.31744/einstein_journal/2025ao0713
Verify or expand the search:
- PubMed search for NCT03385837
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure，Congestive
Currently open trials in the same condition.
- NCT06819618 — Prediction of Heart-Failure with Machine Learning · recruiting
- NCT06350695 — The ROle of Compression StocKings in Heart Failure Patients · NA · recruiting
- NCT06176131 — The Cardio-share Telemedicine Cross-sector Collaboration Model for Managing Vulnerable Patients With Heart Failure · recruiting
- NCT06324682 — ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing · recruiting
- NCT04179643 — AB-1002 in Patients With Class III Heart Failure · Phase 1 · active not recruiting
Other Hospital Israelita Albert Einstein trials
Trials by the same sponsor.
- NCT07447674 — ED Post-Discharge Digital Follow-Up: A Communication Comparison · NA · not yet recruiting
- NCT07398222 — Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study · recruiting
- NCT07233837 — Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units · NA · recruiting
- NCT06726707 — COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis · Phase 2, PHASE3 · withdrawn
- NCT07112846 — Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03385837 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Israelita Albert Einstein
- Last refreshed: 9 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03385837.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing